Multifamily Financing in Philadelphia, PA

Philadelphia's economic foundation rests on an unusually dense concentration of academic medical centers and pharmaceutical and life sciences firms that few metros outside Boston can match. Penn Medicine, Jefferson Health, Temple University Health System, Children's Hospital of Philadelphia, and the Wistar Institute together employ tens of thousands of workers and anchor a research corridor stretching through University City that has absorbed several million square feet of wet-lab and medical office space over the past decade, with additional purpose-built lab product now under construction and in planning. Drexel University, the University of Pennsylvania, and Thomas Jefferson University generate persistent multifamily demand in West Philadelphia and Graduate Hospital, neighborhoods where cap rate compression has been among the sharpest in the mid-Atlantic. GlaxoSmithKline's North American headquarters in Navy Yard and a growing cluster of cell and gene therapy companies, including those spinning out of Penn's gene therapy program, have made the southern waterfront submarket a legitimate underwriting conversation for life sciences industrial and flex product. King of Prussia, driven by corporate back-office and suburban Class A office tenants tied to the financial and defense contracting sectors, remains one of the top suburban office markets east of the Mississippi, though vacancy there reflects the same hybrid-work headwinds pressuring comparable suburban nodes nationally. Industrial demand across South Jersey and the I-95 corridor is supported by last-mile logistics operators serving one of the densest consumer populations on the East Coast. Pennsylvania's Keystone Opportunity Zones and historic tax credit program add a meaningful layer of deal structuring complexity that rewards borrowers who engage counsel early.